News

share

Johnson & Johnson company Janssen-Cilag International (Janssen) has submitted an extended marketing authorisation application (MAA) to the European...

share

A new report commissioned by Cancer Research UK has revealed that thousands of cancer patients in England are...

share

Swiss drugmaker Roche has partnered with Janus Biotherapeutics to develop a small molecule toll-like receptor (TLR) inhibitor with...

share

US-based pharmaceutical firm Cempra has received fast track designation from the US Food and Drug Administration (FDA) for...

share

US-based Madison Vaccines Incorporated (MVI) has started dosing in a clinical trial of its lead prostate cancer vaccine...

share

US-based Pfenex has received a $143.5m five-year contract from the Biomedical Advanced Research and Development Authority (BARDA) of...

share

US-based Aveo Oncology has entered an exclusive and worldwide licence agreement with Swiss drugmaker Novartis to develop and...

share

Hemispherx Biopharma (HEB), announced that as the Company works toward the re-launch of Alferon N, it has extended...